Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 3 of the 11 sources its claims cite were checked for support.
Abstract
The quantitative contributions of pancreatic responsiveness and insulin sensitivity to glucose tolerance were measured using the "minimal modeling technique" in 18 lean and obese subjects (88-206% ideal body wt). The individual contributions of insulin secretion and action were measured by interpreting the dynamics of plasma glucose and insulin during the intravenous glucose tolerance test in terms of two mathematical models. One, the insulin kinetics model, yields parameters of first-phase (phi 1) and second-phase (phi 2) responsivity of the beta-cells to glucose. The other glucose kinetics model yields the insulin sensitivity parameters, SI. Lean and obese subjects were subdivided into good (KG greater than 1.5) and lower (KG less than 1.5) glucose tolerance groups. The etiology of lower glucose tolerance was entirely different in lean and obese subjects. Lean, lower tolerance was related to pancreatic insufficiency (phi 2 77% lower than in good tolerance controls [P less than 0.03]), but insulin sensitivity was normal (P greater than 0.5). In contrast, obese lower tolerance was entirely due to insulin resistance (SI diminished 60% [P less than 0.01]); pancreatic responsiveness was not different from lean, good tolerance controls (phi 1: P greater than 0.06; phi 2: P greater than 0.40). Subjects (regardless of weight) could be segregated into good and lower tolerance by the product of second-phase beta-cell responsivity and insulin sensitivity (phi 2 . SI). Thus, these two factors were primarily responsible for overall determination of glucose tolerance. The effect of phi 1 was to modulate the KG value within those groups whose overall tolerance was determined by phi 2 . SI. This phi 1 modulating influence was more pronounced among insulin sensitive (phi 1 vs. KG, r = 0.79) than insulin resistant (obese, low tolerance; phi 1 vs. KG, r = 0.91) subjects. This study demonstrates the feasibility of the minimal model technique to determine the etiology of impaired glucose tolerance.
Overview
CoChat Summary
TL;DR
The paper applies the “minimal modeling” technique to intravenous glucose tolerance tests in 18 lean and obese subjects to quantify insulin sensitivity and β-cell glucose responsiveness. It finds that low glucose tolerance in lean subjects is due mainly to pancreatic insufficiency, whereas in obese subjects it is due mainly to insulin resistance.
Key findings
- Lean subjects with lower glucose tolerance had a 77% lower second-phase β-cell responsivity (φ2) than lean good-tolerance controls (P < 0.03), while insulin sensitivity was normal (P > 0.5).
- Obese subjects with lower glucose tolerance had insulin sensitivity diminished by 60% versus lean good-tolerance controls (P < 0.01), with pancreatic responsiveness not significantly different (φ1: P > 0.06; φ2: P > 0.40).
- The product φ2·S segregated tolerance: good-tolerance subjects averaged 160 ± 26 versus 40 ± 7 for low-tolerance subjects (P < 0.001); a φ2·S threshold of 75 separated 9 of 10 low-tolerance and 7 of 8 good-tolerance subjects.
- First-phase responsivity (φ1) modulated KG within groups: φ1 vs KG correlated r = 0.79 in insulin-sensitive subjects and r = 0.91 in insulin-resistant obese low-tolerance subjects; glucose effectiveness (P1) was lower in low-tolerance subjects (1.4 ± 0.2 vs. 3.6 ± 0.3 %/min, P < 0.01).
Methods
- IVGTT was performed in 18 subjects (8 male, 10 female; 88–206% ideal body weight) after an overnight fast, with 300 mg/kg glucose injected over 60 s and frequent plasma glucose and insulin sampling.
- Two minimal mathematical models were used: a glucose kinetics model to estimate insulin sensitivity (S) and an insulin kinetics model to estimate first-phase (φ1) and second-phase (φ2) β-cell responsivity to glucose.
- Parameters were estimated by nonlinear least squares with covariance-matrix accuracy assessment; subjects were divided into good tolerance (KG > 1.5) and lower tolerance (KG < 1.5), and comparisons used Student’s t test and regression.
Limitations
- The paper states that complete validation of the model and optimal input patterns is required before the approach can be proposed as a clinical tool, and that more study of the range of glucose doses over which the model applies would be worthwhile.
- The authors note that the present studies were limited to testing whether the model and its parameters apply and can be obtained from other doses and stimulus patterns.
- Evident from the text: the sample is small (n = 18), the tolerance cutoff at KG = 1.5 was arbitrary because no KG values fell between 1.4 and 1.8, and φ1 varied widely within groups, limiting clear segregation by φ1·S.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




![FiGURE 4 Ability of the minimal models to describe glucose and insulin kinetics during the IVGTT (examples). Insulin and glucose data are represented by open (O) and filled () circles. Prediction of the insulin kinetics model are the solid curves; upper panels. Glucose kinetics model predicts the time-course of plasma glucose (solid curves, lower panels) as well as the timecourse of "insulin action" (dashed line upper panels; remote insulin [X] in the model of Fig. la).](https://figures.cochat.ai/paper-figures/f6e06f75ebdc4bef964605372991c28c/physiologic-evaluation-of-factors-controlling-glucose-tolerance-in-man-figure-4.png)



Verification
Claims the paper makes
2 Valid · 0 Not valid · 4 Not checked · 44 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“During the past decade, several laboratories have approached this problem by breaking the feedback relationship, either by pharmacological suppression of pancreatic insulin secretion (10) or by external feedback control (glucose clamp) to circumvent the effect of plasma insulin to change plasma glucose (11).”
What the sources say
- Supportedcites [10] 10. Shen, S-W., G. M. Reaven, and J. W. Farquhar. 1970. Comparison of impedance to insulin-mediated glucose uptake in normal and diabetic subjects.J. Clin. Invest. 49: 2151-2160. source
The Introduction (p. 1, 'Dr. Shen is a Postdoctoral Research Fellow' section) states the approach the citing sentence attributes to this reference: subjects received a constant intravenous infusion of exogenous crystalline insulin while 'endogenous insulin secretion was inhibited by the simultaneous administration of low doses of epinephrine and propranolol,' so that the steady-state plasma glucose during a constant glucose infusion measures impedance to insulin-mediated glucose uptake, and such measurements 'should eliminate some of the variables of an intact feedback loop.' The Discussion ('§ Values obtained from') confirms the pharmacological blockade worked (immunoreactive insulin fell to <50% of fasting and remained low despite plasma glucose of 316 and 398 mg/100 ml), and that its primary goal was to consider only a constant level of exogenous insulin. Our copy does not describe external feedback control (glucose clamp), but that half of the sentence is carried by the separate citation (11), not by this source; likewise 'during the past decade, several laboratories' is the citing authors' framing. Note the propranolol-epinephrine inhibition method is credited to Porte (ref 36), but Shen et al. report and rely on it as their own experimental approach, so the identification citation stands. (LLM, conf=0.88)
- Supportedcites [11] 11. Insel, P. A., J. E. Liljenquist, J. D. Tobin, R. S. Sherwin, P. Watkins, R. Andres, and M. Berman. 1975. Insulin control of glucose metabolism in man. J. Clin. Invest. 55: 1057-1066. source
The citation is attached to the glucose-clamp branch of the sentence (the pharmacological-suppression branch carries a different reference), and our copy is exactly that kind of work: the Introduction (p. 1057) states that 'the maintenance of blood sugar in man is a complex process involving feedback control of insulin on glucose and of glucose on insulin' and that 'by use of the glucose clamp technique (1, 2), the blood glucose concentration is maintained by a feedback-controlled glucose infusion.' The Abstract (p. 1057) confirms the purpose — insulin-induced changes in blood glucose activate counterregulatory mechanisms, 'to eliminate such mechanisms, we have employed the glucose clamp technique which allows maintenance of fasting blood glucose concentration,' and the Discussion (p. 1063) presents the clamp (with kinetic modeling) as an approach to estimating tissue sensitivity to insulin, contrasting it with the insulin tolerance test and 'glucose impedance.' The 'several laboratories' framing is the citing authors' own summary, not a point attributed to this source. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Thus, our results are consistent with the diminished S of obese subjects elucidated by both qualitative (26) and quantitative techniques (25).”
What the sources say
- Not checked — no full text of the sourcecites [26] 26. Kolterman, O., G. M. Reaven, and J. M. Olefsky. 1979. Relationship between in vivo insulin resistance and decreased insulin receptors in obese men. J. Clin. Endocrinol. Metab. 48: 487-494. source
- Supportedcites [25] 25. DeFronzo, R., V. Soman, R. Sherwin, R. Hendler, and P. Felig. 1979. Insulin binding to monocytes and insulin action in human obesity, starvation and refeeding. J. Clin. Invest. 63: 204–213. source
The citation is attached to “quantitative techniques.” The Discussion reports that insulin sensitivity was quantified with the euglycemic insulin clamp and was 52% lower in postabsorptive obese subjects. This supports the attributed finding of diminished insulin sensitivity (S); the qualitative-techniques citation is separate. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the obese glucose space exceeded the space of lean individuals by only 16% (Table II).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“an increase of φ1 from 1 to 10 was associated with an increase in KG of only 0.3 min−¹.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because the diminished glucose effectiveness of obese subjects is independent of acute changes in insulin”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
27 more claims
Create a free account to see all 50 claims and every source verdict.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 14
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As postulated previously [93], we found that the relationship between insulin sensitivity and insulin secretion is non-linear and best described by a hyperbolic function.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [93]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies have demonstrated that to maintain glucose homeostasis, a feedback loop exists in which decreased insulin sensitivity is tightly associated with increased insulin secretion from the beta cell, with this hyperbolic relationship between beta cell responsivity and insulin sensitivity termed the disposition index67,68.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [68]
Experimental — accuracy not yet measuredIn the citing paper
“the product of insulin sensitivity and the acute insulin response to intravenous glucose, called the disposition index [93], declined in the group as a whole and was associated with a mild deterioration of intravenous glucose tolerance.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 6 | 1.06 | 8.9 | 5.1 | 1.4 | 4.5 |”
Reported 4.5 · recomputed 45.39
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ RESULTS · p. 7
“In the glucose kinetics model (Fig. 1b) the coefficient P1 is the insulin-independent fractional turnover constant for glucose disposition”
§ B MINIMAL MODEL OF INSULIN KINETICS · p. 3
“(B) Model of insulin kinetics used to calculate pancreatic responsivity parameters φ1 and φ2 (12).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ METHODS · p. 2
“glucose (300 mg/kg) was injected smoothly over 60 s, starting at time (t) = 0.”
§ RESULTS · p. 6
“Glucose (330 mg/kg) was injected over 1 min starting at t = 0.”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1172/jci109108 · retraction date not known · this paper published 1981-12-01
Citations
Cites
1 retracted
Insulin Binding to Monocytes and Insulin Action in Human Obesity, Starvation, and Refeeding
Defronzo, R. A., Soman, V., Sherwin, R. S., Hendler, R., & Felig, P. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109108 · Cited by 252
RetractedQuantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 4×
“We have referred to the sum of these factors as "glucose effectiveness" (13).”
InfluentialSelf-citationExcessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay
Karam, J. H., Grodsky, G. M., Forsham, P. H., & McWilliams, N. B. (1963) · Diabetes · doi:10.2337/diab.12.3.197 · Cited by 591
Rabinowitz, D., & Zierler, K. L. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104676 · Cited by 521
Shen, S.-W., Reaven, G. M., & Farquhar, J. W. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106433 · Cited by 494
A model of the kinetics of insulin in man
Sherwin, R. S., Kramer, K. J., Tobin, J. D., Insel, P. A., Liljenquist, J. E., Berman, M., & Andres, R. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107697 · Cited by 460
A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling
Grodsky, G. M. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107011 · Cited by 395
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Statistical Analysis: A Computer Oriented Approach.
Pektau, A. J., Afifi, A. A., & Azen, S. P. (1980) · Journal of the American Statistical Association · doi:10.2307/2287217 · Cited by 324
Toffolo, G., Bergman, R. N., Finegood, D. T., Bowden, C. R., & Cobelli, C. (1980) · Diabetes · doi:10.2337/diab.29.12.979 · Cited by 292
Self-citation
Research works printed but not linked: 2
- [18]18. Goodwin, C., and R. L. Payne. 1977. Dynamic System Identification. Academic Press, Inc., New York.
- [14]14. Bergman, R. N., C. R. Bowden, and C. Cobelli. 1981. The minimal model approach to quantification of factors controlling glucose disposal in man. In Carbohydrate Metabolism: Quantitative Physiology and Mathematical Modeling. C. Cobelli, and R. Bergman, editors. John Wiley & Sons, Inc., London. 269–296.
Cited by
Items 801–900 of 1,647
Mechanisms for increased risk of diabetes in chronic liver diseases
Svegliati‐Baroni, G., Gaggini, M., Carli, F., Barbieri, C., Cucco, M., Younes, R., Rosso, C., Bugianesi, E., & Gastaldelli, A. (2020) · Liver International · doi:10.1111/liv.14556 · Cited by 17
Chase, J. G., Wong, X., Singh-Levett, I., Hollingsworth, L., Hann, C. E., Shaw, G. M., Lotz, T., & Lin, J. (2007) · Control Engineering Practice · doi:10.1016/j.conengprac.2007.04.009 · Cited by 18
Hung, Y., Hsieh, C., Pei, D., Kuo, S., Lee, J., Wu, L., He, C., Lee, C., Fan, S. C., & Sheu, W. H. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02178.x · Cited by 18
KARTONO, A. P. (2013) · Theory in Biosciences · doi:10.1007/s12064-013-0181-8 · Cited by 17
Robust Blood-Glucose Control using Mathematica
Kovács, L., Paláncz, B., Benyó, B. I., Torok, L., & Benyó, Z. (2006) · Conference proceedings · doi:10.1109/iembs.2006.259916 · Cited by 19
Konrad, T., ller, T. S., Vicini, P., TOFFOLO, G. M., Grewerus, D., ller, A. S., Bechstein, W. O., Usadel, K. H., Cobelli, C., & Neuhaus, P. (2000) · Transplantation · doi:10.1097/00007890-200005270-00017 · Cited by 19
Self-citationInsulin sensitivity is unaltered by the use of the Norplant® subdermal implant contraceptive
Koopersmith, T. B., & Lobo, R. A. (1995) · Contraception · doi:10.1016/0010-7824(95)00016-4 · Cited by 17
Anti‐lipolytic Effects of Insulin in African American and White Prepubertal Boys
Gower, B. A., Herd, S. L., & Goran, M. I. (2001) · Obesity Research · doi:10.1038/oby.2001.25 · Cited by 18
Martin, I. K., Weber, K. M., Ward, G. M., Best, J. D., & Boston, R. C. (1990) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(90)90070-p · Cited by 19
Coates, P. A., Ollerton, R. L., Luzio, S. D., Ismail, I. S., & Owens, D. R. (1993) · Diabetes · doi:10.2337/diab.42.11.1635 · Cited by 24
An automatic deep reinforcement learning bolus calculator for automated insulin delivery systems
Ahmad, S., Beneyto, A., Zhu, T., Contreras, I., Georgiou, P., & Vehí, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-62912-4 · Cited by 31
Schwarz, P. E. H., Towers, G. W., van der Merwe, A., Perez-Perez, L., Rheeder, P., Schulze, J., Bornstein, S. R., Licinio, J., Wong, M., Schutte, A. E., et al. (2008) · The Pharmacogenomics Journal · doi:10.1038/tpj.2008.2 · Cited by 16
Raissouni, N., Kolesnikov, A., Purushothaman, R., SINHA, S. K., Bhandari, S., Bhangoo, A., Malik, S., Mathew, R. P., Baillargeon, J., Hernández, M. I., et al. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-14 · Cited by 19
Boiroux, D., Bátora, V., Hagdrup, M., Tárnik, M., Murgaš, J., Schmidt, S., Nørgaard, K., Poulsen, N. K., Madsen, H., & Jørgensen, J. B. (2015) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2015.10.106 · Cited by 16
“Even the most simple physiological models for people with T1D, such as the minimal model developed by Bergman et al. (1981), may be difficult to identify, as shown in Pillonetto et al.”
BackgroundMethodMurata, M., Adachi, H., Oshima, S., & Kurabayashi, M. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.007 · Cited by 17
Gautier, Y., Luneau, I., Coquery, N., Meurice, P., Malbert, C., Guérin, S., Kemp, B., Bolhuis, J. E., Clouard, C., Huërou‐Luron, I. L., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701541 · Cited by 20
Adams, J. D., & Vella, A. V. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0024 · Cited by 20
Shuster, D. L., Shireman, L. M., Ma, X., Shen, D. D., Flood-Nichols, S. K., Ahmed, M. S., Clark, S. M., Caritis, S. N., Venkataramanan, R., Haas, D. M., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1749 · Cited by 20
Dias, C. C., Kamath, S. R., & Vidyasagar, S. (2020) · IET Systems Biology · doi:10.1049/iet-syb.2019.0101 · Cited by 22
Trafficking of nonesterified fatty acids in insulin resistance and relationship to dysglycemia
Walker, R. E., Ford, J. L., Boston, R. C., Savinova, O. V., Harris, W. S., Green, M. H., & Shearer, G. C. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00331.2019 · Cited by 17
Linear Modeling and Prediction in Diabetes Physiology
Cescon, M., & Johansson, R. (2014) · Lecture notes in bioengineering · doi:10.1007/978-3-642-54464-4_9 · Cited by 19
13C- and 2H-labelled glucose compared for minimal model estimates of glucose metabolism in man
Bluck, L. J. C., Clapperton, A. T., & Coward, W. A. (2005) · Clinical Science · doi:10.1042/cs20050155 · Cited by 15
A switching control strategy for the attenuation of blood glucose disturbances
Markakis, M. G., Mitsis, G. D., Papavassilopoulos, G. P., Ioannou, P., & Marmarelis, V. Z. (2009) · Optimal Control Applications and Methods · doi:10.1002/oca.900 · Cited by 17
Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin
Messer, C., Boston, R., Leroith, D., Geer, E., Miller, J. D., Messer, M., & Futterweit, W. (2012) · Endocrine Practice · doi:10.4158/ep11375.or · Cited by 16
“The product of AIRg and insulin sensitivity yields the disposition index, which is an estimate of the degree of β-cell compensation for insulin resistance (15,17,18).”
BackgroundOptimal homeostasis necessitates bistable control
Wang, G. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0244 · Cited by 17
Yeom, J.-A., Kim, E.-S., Park, H., Ham, D., Sun, C., Kim, J.-W., Cho, J., & Yoon, K. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.11.713 · Cited by 18
Tadros, E. M., Frank, N., Witte, F. D., & Boston, R. C. (2013) · American Journal of Veterinary Research · doi:10.2460/ajvr.74.7.1020 · Cited by 26
Positive sliding mode control for blood glucose regulation
Menani, K., MohammadRidha, T., Magdelaine, N., Abdelaziz, M., & Moog, C. H. (2017) · International Journal of Systems Science · doi:10.1080/00207721.2017.1381893 · Cited by 19
Insulin Resistance in Pregnancy: Implications for Mother and Offspring
Hernandez, T. L., Friedman, J. E., & Barbour, L. A. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_5 · Cited by 25
Run-to-run control strategy for diabetes management
Doyle, F., Srinivasan, B., & Bonvin, D. (2005) · Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society · doi:10.1109/iembs.2001.1019492 · Cited by 16
Impact of Acute Biochemical Castration on Insulin Sensitivity in Healthy Adult Men
Rabiee, A., Dwyer, A. A., Caronia, L. M., Hayes, F. J., Yialamas, M. A., Andersen, D. K., Thomas, B. J., Torriani, M., & Elahi, D. (2010) · Endocrine Research · doi:10.3109/07435801003705601 · Cited by 19
Abnormalities in Insulin Secretion in Type 2 Diabetes Mellitus
Meas, T., & Guillausseau, P.-J. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch3 · Cited by 16
Yildirim, V., Sheraton, V. M., Brands, R., Crielaard, L., Quax, R., van Riel, N. A. W., Stronks, K., Nicolaou, M., & Sloot, P. M. A. (2023) · iScience · doi:10.1016/j.isci.2023.108324 · Cited by 19
Chen, G., Tan, C., Liu, X., Wang, X., Tan, Q., & Chen, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030756 · Cited by 15
Sun, Y., & Kosmas, P. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3472077 · Cited by 19
Vafamand, N., Mardani, M. M., Khayatian, A., et al. (2017) · IET Control Theory and Applications · doi:10.1049/iet-cta.2017.0096 · Cited by 15
Grosman, B., Wu, D., Parikh, N., Roy, A., Voskanyan, G. R., Kurtz, N., Sturis, J., Cohen, O., Ekelund, M., & Vigersky, R. A. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106087 · Cited by 18
Farkas, G. J., Gordon, P., Trewick, N., Gorgey, A. S., Dolbow, D. R., Tiozzo, E., Berg, A. S., & Gater, D. R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235591 · Cited by 20
Robust nonlinear control of blood glucose in diabetic patients subject to model uncertainties
Farahmand, B., Dehghani, M., Vafamand, N., Mirzaee, A., Boostani, R., & Pieper, J. K. (2022) · ISA Transactions · doi:10.1016/j.isatra.2022.07.009 · Cited by 16
Burattini, R., Nardo, F. D., Casagrande, F., Boemi, M., & Morosini, P. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.010 · Cited by 15
Horie, I., Kawasaki, E., Sakanaka, A., Takashima, M., Maeyama, M., Ando, T., Hanada, H., & Kawakami, A. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.12.011 · Cited by 16
The application of Model Predictive Control to normalize glycemia of critically ill patients
Herpe, T. V., Haverbeke, N., Pluymers, B., den Berghe, G. V., & Moor, B. D. (2007) · European Control Conference (ECC) · doi:10.23919/ecc.2007.7068484 · Cited by 16
Nijpels, G., Boorsma, W., Dekker, J. M., Hoeksema, F., Kostense, P. J., Bouter, L. M., & Heine, R. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2837 · Cited by 17
Amoah, A. G. B., Schuster, D. P., Gaillard, T. R., & Osei, K. (2003) · Diabetologia · doi:10.1007/s00125-003-1130-8 · Cited by 16
Ryder, E., Gómez, M. E., Fernández, V., Campos, G., Morales, L. M., Valbuena, H., & Raleigh, X. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00282-6 · Cited by 18
Bates, H. E., Sirek, A., Kiràly, M. A., Yue, J. T. Y., Riddell, M. C., Matthews, S. G., & Vranić, M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90378.2008 · Cited by 16
Effect of insulin on [3H]deoxy-D-glucose pharmacokinetics in the rat
Furler, S. M., Jenkins, A. B., & Kraegen, E. W. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.255.6.e806 · Cited by 14
On linearity of insulin kinetics
Cobelli, C., Mari, A., & Ferrannini, E. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.251.2.e247 · Cited by 15
Self-citationEfficient Numerical Methods for Moving Horizon Estimation
Haverbeke, N. (2011) · Lirias (KU Leuven) · Cited by 15
TP type polytopic modelling of the Bergman minimal model of the diabetes mellitus
Takarics, B., & Baranyi, P. (2013) · International Conference on Intelligent Engineering Systems · doi:10.1109/ines.2013.6632786 · Cited by 13
A Bayesian network for modelling blood glucose concentration and exercise in type 1 diabetes
Ewings, S. M., Sahu, S. K., Valletta, J. J., Byrne, C. D., & Chipperfield, A. J. (2014) · Statistical Methods in Medical Research · doi:10.1177/0962280214520732 · Cited by 19
Robust multi‐objective blood glucose control in Type‐1 diabetic patient
Mandal, S., & Sutradhar, A. (2019) · IET Systems Biology · doi:10.1049/iet-syb.2018.5093 · Cited by 14
Lin, G., Liu, Q., Dai, A., Cai, X., Zhou, Q., Wang, X., Chen, Y., Ye, C., Li, J., Yang, D., et al. (2020) · Biochemical Journal · doi:10.1042/bcj20200235 · Cited by 13
Sala-Mira, I., Siket, M., Kovács, L., Eigner, G., & Bondía, J. (2021) · IEEE Access · doi:10.1109/access.2021.3120880 · Cited by 16
Mixed Meal Modeling and Disturbance Rejection in Type I Diabetic Patients
Roy, A., & Parker, R. S. (2006) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2006.260372 · Cited by 18
Fish oil diets do not improve insulin sensitivity and secretion in healthy adult male pigs
Castellano, C., Audet, I. B., Laforest, J.-P., Chouinard, P. Y., & Matte, J. J. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509991590 · Cited by 17
Obesity, Type 2 Diabetes and Beta Cell Failure: An Asian Perspective
Saisho, Y. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.s1-008 · Cited by 19
Handling Parameter Variations during the Treatment of Type 1 Diabetes Mellitus: In Silico Results
Villa-Tamayo, M. F., Caicedo, M. A., & Rivadeneira, P. S. (2019) · Mathematical Problems in Engineering · doi:10.1155/2019/2640405 · Cited by 15
DEVELOPMENT OF A CRITICALLY ILL PATIENT INPUT-OUTPUT MODEL
Herpe, T. V., Espinoza, M., Pluymers, B., Wouters, P. J., Smet, F. D., den Berghe, G. V., & Moor, B. D. (2006) · IFAC Proceedings Volumes · doi:10.3182/20060329-3-au-2901.00073 · Cited by 14
Artificial Pancreas Coupled Vital Signs Monitoring for Improved Patient Safety
Khan, Z. H., Khan, Z. H., & Khan, Z. H. (2012) · Arabian Journal for Science and Engineering · doi:10.1007/s13369-012-0456-2 · Cited by 15
Taniguchi, A., Fukushima, M., Nakai, Y., et al. (2005) · Metabolism · doi:10.1016/j.metabol.2004.10.006 · Cited by 14
Araújo‐Vilar, D., Estévez, D. A. G., & Cabezas-Cerrato, J. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90263-3 · Cited by 15
Chen, P.-H., Tsai, Y.-T., Wang, J., Lin, S.-D., Lee, W.-J., Su, S., Lee, I., Tu, S., Tseng, Y., Sheu, W. H., et al. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-68 · Cited by 14
Diabetes Information Technology & WebWatch
Lehmann, E. D. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/15209150050025302 · Cited by 14
Cai, D., Liu, W., Ji, L., & Shi, D. (2021) · Control Engineering Practice · doi:10.1016/j.conengprac.2021.104881 · Cited by 17
de Hoogh, I. M., Pasman, W. J., Boorsma, A., van Ommen, B., & Wopereis, S. (2022) · Biomedicines · doi:10.3390/biomedicines10030643 · Cited by 17
Mathematical modeling of gastrointestinal starch digestion-blood glucose-insulin interactions
Meraz, M., Vernon‐Carter, E. J., Bello‐Pérez, L. A., & Alvarez-Ramirez, J. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2022.103812 · Cited by 14
Casas, B., Vilén, L., Bauer, S., Kanebratt, K. P., Huldt, C. W., Magnusson, L. U., Marx, U., Andersson, T. B., Gennemark, P., & Cedersund, G. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010587 · Cited by 13
Cai, D., Wu, W., Cescon, M., Liu, W., Ji, L., & Shi, D. (2023) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2023.100897 · Cited by 15
Design of Luenberger Observer for Glucose-Insulin Control via Mathematica
Kovács, L., Paláncz, B., & Benyó, Z. (2007) · Conference proceedings · doi:10.1109/iembs.2007.4352367 · Cited by 13
DYNAMIC MODELING OF EXERCISE EFFECTS ON PLASMA GLUCOSE AND INSULIN LEVELS
Roy, A., & Parker, R. S. (2006) · IFAC Proceedings Volumes · doi:10.3182/20060402-4-br-2902.00509 · Cited by 15
Intra-patient dynamic variations in Type 1 Diabetes: A review
Moscoso-Vásquez, M., Colmegna, P. H., & Sánchez‐Peña, R. (2016) · The proceedings of the IEEE Conference on Control Applications/The proceedings of the ... IEEE Conference on Control Applications · doi:10.1109/cca.2016.7587866 · Cited by 17
Schmeltz, L. R., & Metzger, B. E. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00179-6 · Cited by 19
Chandler, P. D., Giovannucci, E. L., Scott, J. B., Bennett, G. G., Ng, K., Chan, A. T., Hollis, B. W., Rifai, N., Emmons, K. M., Fuchs, C. S., et al. (2015) · Scientific Reports · doi:10.1038/srep10411 · Cited by 14
Afghani, A., & GORAN, M. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.07.014 · Cited by 13
Ethnicity and Weight Status Affect the Accuracy of Proxy Indices of Insulin Sensitivit
Alvarez, J. A., Bush, N. C., Hunter, G. R., Brock, D. W., & Gower, B. A. (2008) · Obesity · doi:10.1038/oby.2008.437 · Cited by 15
Wang, L., Zhang, J., Wang, B., Zhang, Y., Hong, J., Zhang, Y., Wang, W., & Gu, W. (2013) · Endocrine · doi:10.1007/s12020-013-9937-7 · Cited by 13
Fereydouneyan, F., Zare, A., & Mehrshad, N. (2011) · Journal of Medical Engineering & Technology · doi:10.3109/03091902.2011.569050 · Cited by 13
Letiexhe, M. R., Scheen, A. J., & Lefèbvre, P. J. (1997) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/bf03339953 · Cited by 13
Murphy, E. A., Pyeritz, R. E., Opitz, J. M., & Reynolds, J. F. (1986) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320240418 · Cited by 13
Glucagon‐like peptide‐1 in type 2 diabetes: the β‐cell and beyond
Nauck, M. A. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00919.x · Cited by 14
Compact energy metabolism model: Brain controlled energy supply
Göbel, B., Langemann, D., Oltmanns, K. M., & Chung, M. (2010) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2010.02.033 · Cited by 15
A mathematical model for the robust blood glucose tracking
Liu, W. (2019) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2019036 · Cited by 13
Vidmar, A. P., Durazo-Arvizú, R., Weigensberg, M. J., Alderete, T. L., & Goran, M. I. (2023) · Diabetes · doi:10.2337/db22-1034 · Cited by 13
Glucose-Insulin System Based on Minimal Model: A Realistic Approach
Gonzalez, A. A., Voos, H., & Darouach, M. (2015) · UKSim International Conference on Computer Modelling and Simulation (UKSim) · doi:10.1109/uksim.2015.65 · Cited by 12
Breiman's Two Cultures: You Don't Have to Choose Sides
Miller, A. C., Foti, N. J., & Fox, E. B. (2021) · Observational Studies · doi:10.1353/obs.2021.0003 · Cited by 20
Åhrén, B. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13564 · Cited by 15
Grosman, B., Parikh, N., Roy, A., LINTEREUR, L. J., Vigersky, R. A., Cohen, O., & Rhinehart, A. S. (2022) · Annals of Biomedical Engineering · doi:10.1007/s10439-022-03079-9 · Cited by 13
Eberle, C., & Ament, C. (2011) · Biosystems · doi:10.1016/j.biosystems.2011.11.003 · Cited by 16
Strategies for Glucose Control in People with Type 1 Diabetes
Boiroux, D., Finan, D. A., Jørgensen, J. B., Poulsen, N. K., & Madsen, H. (2011) · IFAC Proceedings Volumes · doi:10.3182/20110828-6-it-1002.03714 · Cited by 12
Brock, D. W., Irving, B. A., Gower, B., & Hunter, G. R. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.133 · Cited by 12
Asymptotic output tracking in blood glucose control. A case study
Kovács, L., Szalay, P., Benyó, B. I., & Chase, G. J. (2011) · IEEE Conference on Decision and Control (CDC) · doi:10.1109/cdc.2011.6161400 · Cited by 12
Henriksen, J. E., ALFORD, F. P., Ward, G. M., Thye‐Rønn, P., Levin, K., Nielsen, O. H., Rantzau, C., Boston, R., & Beck‐Nielsen, H. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1127 · Cited by 12
A Review of Mathematical Model Describing Insulin Delivery System for Type 1 Diabetes
Yusof, N. F. M., Som, A. M., Ibrehem, A. S., & Ali, S. A. (2014) · Journal of Applied Sciences · doi:10.3923/jas.2014.1465.1468 · Cited by 12
Marchetti, L., Reali, F., Dauriz, M., Brangani, C., Boselli, L., Ceradini, G., Bonora, E., Bonadonna, R. C., & Priami, C. (2016) · Scientific Reports · doi:10.1038/srep36029 · Cited by 12
A feedback glucose control strategy for type II diabetes mellitus based on fuzzy logic
Ekram, F., Sun, L., Vahidi, O., Kwok, E., & Gopaluni, R. B. (2012) · The Canadian Journal of Chemical Engineering · doi:10.1002/cjce.21667 · Cited by 17
Wang, Y., Fang, M., Jiang, X., Bequette, B. W., & Xie, H. (2014) · Journal of Process Control · doi:10.1016/j.jprocont.2013.12.012 · Cited by 13
Dynamic modeling of methylprednisolone effects on body weight and glucose regulation in rats
Fang, J., DuBois, D. C., He, Y., Almon, R. R., & Jusko, W. J. (2011) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-011-9194-4 · Cited by 15
Discrete time recurrent neural network observer
Salgado, I., & Chaírez, I. (2009) · doi:10.1109/ijcnn.2009.5178900 · Cited by 12
Comparison of Two Commonly Used Standard IVGTTs
Colman, P. G., Stewart, V., Kean, J., Koschmann, M., ALFORD, F. P., Ward, G., Deam, D. R., & Harrison, L. C. (1992) · Diabetes Care · doi:10.2337/diacare.15.8.1053 · Cited by 12
Metadata
- Authors
- Bergman, R. N., Phillips, L. S., & Cobelli, C.
- Affiliations
- Northwestern University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1981-12-01
- Volume
- 68
- Issue
- 6
- Pages
- 1456-1467
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC370948
- OpenAlex
- W2156353972
- Cited by
- 1,640
- References
- 30
- Citations by year
- 2026: 32 · 2025: 38 · 2024: 44 · 2023: 31 · 2022: 45 · 2021: 59 · 2020: 50 · 2019: 55 · 2018: 66 · 2017: 66 · 2016: 59 · 2015: 63 · 2014: 60 · 2013: 59 · 2012: 73
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Northwestern University
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK029867)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glucose tolerance, insulin sensitivity, beta-cell glucose sensitivity, insulin resistance, pancreatic insufficiency, intravenous glucose tolerance test, first-phase insulin response, second-phase insulin response, obesity, impaired glucose tolerance, insulin kinetics, glucose kinetics
- MeSH terms
- Body Weight, Female, Glucose, Glucose Tolerance Test, Humans, Infusions, Parenteral, Insulin, Kinetics, Male, Models, Biological, Obesity, Pancreas
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.